(Q80185157)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

Nader Rifai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

5

Shehzad Basaria

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

9

Elizabeth A Platz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Sabine Rohrmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

William G Nelson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Norma Kanarek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Konstantinos K Tsilidis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ellen Smit

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Edward Giovannucci

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

708-713

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

The development of human benign prostatic hyperplasia with age

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Role of estrogens in human benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Influence of Age and Endocrine Factors on the Volume of Benign Prostatic Hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

From estrogen to androgen receptor: a new pathway for sex hormones in prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

A critical evaluation of simple methods for the estimation of free testosterone in serum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Plasma steroid hormones, surgery for benign prostatic hyperplasia, and severe lower urinary tract symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Relationship of serum sex-steroid hormones and prostate volume in African American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Androgen metabolism in men receiving finasteride before prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Endocrine environment of benign prostatic hyperplasia: prostate size and volume are correlated with serum estrogen concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Serum sex hormones and measures of benign prostatic hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Possible mechanism of induction of benign prostatic hyperplasia by estradiol and dihydrotestosterone in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Relationship between upregulated oestrogen receptors and expression of growth factors in cultured, human, prostatic stromal cells exposed to estradiol or dihydrotestosterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2007.01.011

10.1016/J.UROLOGY.2007.01.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17445656%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference